AUBEPINE MACERAT GLYCERINE
Food supplement declared in France, declaration No 2022-3-597, decision dated 14 March 2022
AUBEPINE MACERAT GLYCERINE (Laboratoire Santarel) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Crataegus laevigata 0.45 ml per day. None of the rules we check flags an issue with its declared composition.
- Brand
- Laboratoire Santarel
- Food business operator placing the product on the market
- PBO
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Dropper
- Daily dose
- 15 gouttes
- Directions for use
- Prendre 5 gouttes 3 fois par jour avec un verre d'eau
- Not recommended (according to the manufacturer)
- Breastfeeding women, Pregnant women
Declaration 324019, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Crataegus laevigata (Poir.) DC. | Bourgeon | Autre macérât | 0.45 ml |
Additives
E422
Other ingredients
Eau purifiée, Alcool
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Ne pas dépasser la dose journalière recommandée. Ce complément alimentaire ne se substitue pas à une alimentation variée et équilibrée et à un mode de vie sain. Tenir hors de la portée des jeunes enfants. A conserver au frais et à l’abri de la lumière. Déconseillé aux femmes enceintes ou allaitantes
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Crataegus laevigata (Poir.) DC.
Read the warning, when it applies and the studies cited
Hawthorn
Route of administration: Oral (ESCOP 2009; Bradley 2006; Mills and Bone 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking cardiac glycosides (e.g., digoxin) or blood pressure or heart medications (Brinker 2010; Bradley 2006).
Sources cited by Health Canada (2)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have chest pain, irregular heartbeat, or shortness of breath.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- AUBEPINE MACERAT GLYCERINE SANTAREL, declared in 2020, withdrawn from the market : different composition: 1 ingredient(s) added, 1 missing
Brand : Laboratoire Santarel
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “AUBEPINE MACERAT GLYCERINE (Laboratoire Santarel): composition and regulation”, https://compoatlas.com/en/supplements/products/324019-aubepine-macerat-glycerine, updated 15 November 2026.